PDT Partners’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-138,123
| Closed | -$369K | – | 993 |
|
|
2022
Q1 | $369K | Buy |
138,123
+3,000
| +2% | +$8.02K | 0.03% | 653 |
|
|
2021
Q4 | $585K | Buy |
135,123
+29,315
| +28% | +$127K | 0.04% | 488 |
|
|
2021
Q3 | $539K | Buy |
105,808
+30,064
| +40% | +$153K | 0.04% | 462 |
|
|
2021
Q2 | $479K | Buy |
75,744
+31,132
| +70% | +$197K | 0.03% | 525 |
|
|
2021
Q1 | $345K | Sell |
44,612
-39,822
| -47% | -$308K | 0.02% | 582 |
|
|
2020
Q4 | $553K | Sell |
84,434
-23,664
| -22% | -$155K | 0.04% | 434 |
|
|
2020
Q3 | $719K | Sell |
108,098
-4,421
| -4% | -$29.4K | 0.05% | 368 |
|
|
2020
Q2 | $937K | Buy |
112,519
+33,819
| +43% | +$282K | 0.06% | 294 |
|
|
2020
Q1 | $604K | Sell |
78,700
-19,457
| -20% | -$149K | 0.05% | 326 |
|
|
2019
Q4 | $816K | Buy |
98,157
+8,120
| +9% | +$67.5K | 0.05% | 321 |
|
|
2019
Q3 | $664K | Buy |
+90,037
| New | +$664K | 0.04% | 315 |
|